This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khashe, S.
Right arrow Articles by Janda, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khashe, S.
Right arrow Articles by Janda, J. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 1998, p. 783-787, Vol. 36, No. 3
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Biochemical and Pathogenic Properties of Shewanella alga and Shewanella putrefaciens

Shideh Khashe and J. Michael Janda*

Microbial Diseases Laboratory, Division of Communicable Disease Control, California Department of Health Services, Berkeley, California 94704-1011

Received 10 October 1997/Returned for modification 24 November 1997/Accepted 15 December 1997

We characterized 49 strains of Shewanella spp. from clinical (n = 31) and nonhuman (n = 18) sources. Most Shewanella alga organisms (Gilardi biovar 2; Centers for Disease Control and Prevention [CDC] biotype 2) originated from clinical material (92%), failed to produce acid from carbohydrates other than D-ribose, and were biochemically and enzymatically fairly homogeneous. In contrast, Shewanella putrefaciens organisms (Gilardi biovars 1 and 3; CDC biotype 1) were more often associated with nonhuman sources (70%), were able to utilize a number of sugars (sucrose, L-arabinose, and maltose), and were found to exhibit wider variations in biochemical characteristics; three biotypes within S. putrefaciens were detected. Notable differences between the two species in enzymatic activity, determined with the API-ZYM system (bioMérieux, Hazelwood, Mo.), and cellular fatty acid profiles, determined by the MIDI system (Microbial ID Inc., Newark, Del.), were also detected. Pathogenicity studies of mice indicate that S. alga appears to be the more virulent species, possibly due to the production of a hemolytic substance.

* Corresponding author. Mailing address: Microbial Diseases Laboratory, 2151 Berkeley Way, Berkeley, CA 94704-1011. Phone: (510) 540-2242. Fax: (510) 540-2374. E-mail: jjanda{at}hw1.cahwnet.gov.

Journal of Clinical Microbiology, March 1998, p. 783-787, Vol. 36, No. 3
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Park, S. C., Baik, K. S., Kim, M. S., Kim, D., Seong, C. N. (2009). Shewanella marina sp. nov., isolated from seawater. Int. J. Syst. Evol. Microbiol. 59: 1888-1894 [Abstract] [Full Text]  
  • Richards, G. P., Watson, M. A., Crane, E. J. III, Burt, I. G., Bushek, D. (2008). Shewanella and Photobacterium spp. in Oysters and Seawater from the Delaware Bay. Appl. Environ. Microbiol. 74: 3323-3327 [Abstract] [Full Text]  
  • Kim, D., Baik, K. S., Kim, M. S., Jung, B.-M., Shin, T.-S., Chung, G.-H., Rhee, M. S., Seong, C. N. (2007). Shewanella haliotis sp. nov., isolated from the gut microflora of abalone, Haliotis discus hannai. Int. J. Syst. Evol. Microbiol. 57: 2926-2931 [Abstract] [Full Text]  
  • Kim, D.-M., Kang, C.-I., Lee, C. S., Kim, H.-B., Kim, E.-C., Kim, N. J., Oh, M.-d., Choe, K.-W. (2006). Treatment Failure Due to Emergence of Resistance to Carbapenem during Therapy for Shewanella algae Bacteremia.. J. Clin. Microbiol. 44: 1172-1174 [Abstract] [Full Text]  
  • Botelho-Nevers, E., Gouriet, F., Rovery, C., Paris, P., Roux, V., Raoult, D., Brouqui, P. (2005). First Case of Osteomyelitis Due to Shewanella algae. J. Clin. Microbiol. 43: 5388-5390 [Abstract] [Full Text]  
  • O'Hara, C. M. (2005). Manual and Automated Instrumentation for Identification of Enterobacteriaceae and Other Aerobic Gram-Negative Bacilli. Clin. Microbiol. Rev. 18: 147-162 [Abstract] [Full Text]  
  • Heritier, C., Poirel, L., Nordmann, P. (2004). Genetic and Biochemical Characterization of a Chromosome-Encoded Carbapenem-Hydrolyzing Ambler Class D {beta}-Lactamase from Shewanella algae. Antimicrob. Agents Chemother. 48: 1670-1675 [Abstract] [Full Text]  
  • Oliver, J. W. (2003). Ochrobactrum anthropi Misidentified as Shewanella putrefaciens. J. Clin. Microbiol. 41: 4486-4486 [Full Text]  
  • Pagani, L., Lang, A., Vedovelli, C., Moling, O., Rimenti, G., Pristera, R., Mian, P. (2003). Soft Tissue Infection and Bacteremia Caused by Shewanella putrefaciens. J. Clin. Microbiol. 41: 2240-2241 [Abstract] [Full Text]  
  • Ferrandez, A., Hawkins, A. C., Summerfield, D. T., Harwood, C. S. (2002). Cluster II che Genes from Pseudomonas aeruginosa Are Required for an Optimal Chemotactic Response. J. Bacteriol. 184: 4374-4383 [Abstract] [Full Text]  
  • Iwata, M., Tateda, K., Matsumoto, T., Furuya, N., Mizuiri, S., Yamaguchi, K. (1999). Primary Shewanella alga Septicemia in a Patient on Hemodialysis. J. Clin. Microbiol. 37: 2104-2105 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»